Synthetic Lethal Approaches to Cancer Vulnerabilities
Conference - Bellevue, WA, United States
Conference Co-Chairpresons:
William C. Hahn, Dana-Farber Cancer Institute, Boston, MA
Sebastian Nijman, Research Center for Molecular Medicine – CeMM, Vienna, Austria
Louis M. Staudt, National Cancer Institute, Bethesda, MD
The focus of this AACR Special Conference is to bring together basic, translational, and clinical scientists working on targeting codependencies and other context-specific dependencies. The concept of synthetic lethality is derived from classical genetics and has been widely explored in model organisms. Recent advances in technology now permit similar types of studies to be performed in mammalian cells, and the demonstration that PARP inhibitors show clinical responses in breast and ovarian cancer patients that harbor BRCA1 mutations provides proof-of-principle evidence that targeting such codependencies represents a promising therapeutic strategy.
(Courtesy of Hyatt-Regency-Bellevue, WA, via orbitz.com)
AACR Synthetic Lethal Approaches to Cancer Vulnerabilities
Friday, May 17, 2013 - Monday, May 20, 2013
Hyatt Regency Bellevue, Bellevue, WA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
